Related references
Note: Only part of the references are listed.Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness
Lawrence Scahill
CNS DRUGS (2009)
Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
Sharon B. Wigal
CNS DRUGS (2009)
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study
Grazia Dell'Agnello et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
ADHD and Health Services Utilization in the National Health Interview Survey
Steven P. Cuffe et al.
JOURNAL OF ATTENTION DISORDERS (2009)
Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Thomas J. Spencer et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
A Naturalistic Study of Predictors and Risks of Atypical Antipsychotic Use in an Attention-Deficit/Hyperactivity Disorder Clinic
Margaret Weiss et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Floyd R. Sallee et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
Floyd R. Sallee et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2009)
Treatment of Aggressive ADHD in Children and Adolescents: Conceptualization and Treatment of Comorbid Behavior Disorders
Keith McBurnett et al.
POSTGRADUATE MEDICINE (2009)
Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
Florence Levy
BEHAVIORAL AND BRAIN FUNCTIONS (2008)
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
Joseph Biederman et al.
PEDIATRICS (2008)
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder
Mark E. Bangs et al.
PEDIATRICS (2008)
Pharmacokinetics of a Guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder
Samuel W. Boellner et al.
PHARMACOTHERAPY (2007)
Catecholamine and second messenger lnfluences on prefrontal cortical networks of representational knowledge: A rational bridge between genetics and the symptoms of mental illness
Amy F. T. Arnsten
CEREBRAL CORTEX (2007)
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: A population-based perspective
William J. Barbaresi et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2007)
Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Emerging concepts from new data
Amy F. Arnsten et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder
Steven Pliszka et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
α2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex
Min Wang et al.
CELL (2007)
A Phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults
Dennis Swearingen et al.
CLINICAL THERAPEUTICS (2007)
Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast
Neil Easton et al.
PSYCHOPHARMACOLOGY (2006)
α2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals
Brian P. Ramos et al.
LEARNING & MEMORY (2006)
The Texas children's medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder
Steven R. Pliszka et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Attention-deficit hyperactivity disorder
J Biederman et al.
LANCET (2005)
The neuropsychopharmacology of attention-deficit/hyperactivity disorder
SR Pliszka
BIOLOGICAL PSYCHIATRY (2005)
Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: The state of the field and salient challenges for the coming decade
JT Nigg
BIOLOGICAL PSYCHIATRY (2005)
Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions
AFT Arnsten et al.
BIOLOGICAL PSYCHIATRY (2005)
Locomotor hyperactivity induced by blockade of prefrontal cortical α2-adrenoceptors in monkeys
CL Ma et al.
BIOLOGICAL PSYCHIATRY (2005)
Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes
FX Castellanos et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Psychological heterogeneity in AD/HD - a dual pathway model of behaviour and cognition
EJS Sonuga-Barke
BEHAVIOURAL BRAIN RESEARCH (2002)
The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task
RA Avery et al.
NEUROPSYCHOPHARMACOLOGY (2000)
The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy
BE Swartz et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
